 | Up a level |
Aeppli, S; Schmaus, M; Eisen, T; Escudier, B; Grünwald, V; Larkin, J; McDermott, D; Oldenburg, J; Porta, C; Rini, B I; Schmidinger, M; Sternberg, C N; Rothermundt, C; Putora, P.M. (2021). First-line treatment of metastatic clear cell renal cell carcinoma: a decision-making analysis among experts. ESMO open, 6(1), p. 100030. BMJ 10.1016/j.esmoop.2020.100030
Früh, M.; Panje, C.M.; Reck, M; Blackhall, F; Califano, R; Cappuzzo, F; Besse, B; Novello, S; Garrido, P; Felip, E; O'Brien, M; Paz Ares, L; de Marinis, F; Westeel, V; De Ruysscher, D; Putora, P.M. (2020). Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts. Lung cancer, 146, pp. 6-11. Elsevier 10.1016/j.lungcan.2020.03.024
